- CH₣4.36bn
- CH₣5.45bn
- CH₣4.14bn
Swiss stocks - Factors to watch on October 22
Brief: Galenica Sales Up 5.7% To CHF 3.17 Bln In First Nine Months Of 2026, Confirms Outlook
Swiss stocks - Factors to watch on September 2
Switzerland's Galenica H1 sales rise on pharmacy services demand
Brief: Galenica Expects 2026 Adjusted EBIT To Increase By 6%-8%
Swiss stocks - Factors to watch on August 6
Swiss stocks - Factors to watch on May 28
Brief: Galenica - Sales Up 7.3% To CHF 1409.7 MLN In First Four Months 2026
Swiss stocks - Factors to watch on May 20
Swiss stocks - Factors to watch on April 21
Brief: Galenica To Close Production At Bichsel Subsidiary By End Of 2026
Swiss stocks - Factors to watch on March 10
Switzerland's Galenica 2025 sales rise 5.5%; expects 2026 sales growth of 5% to 7%
Galenica falls on plans to shut down unit's pharma production
Galenica plans to end pharma production at Bichsel unit, up to 170 jobs affected
Swiss stocks - Factors to watch on February 24
Brief: Galenica Focuses Bichsel's Business On Home Care Services
Swiss stocks - Factors to watch on January 22
Switzerland's Galenica AG's 2025 sales rise on wholesale expansion, pharmacy growth